Panobinostat for the management of multiple myeloma.
Sign Up to like & getrecommendations! Published in 2017 at "Future oncology"
DOI: 10.2217/fon-2016-0329
Abstract: Multiple myeloma (MM) is the second most common blood cancer following non-Hodgkin's lymphoma. While the treatments for MM have improved over the past decade, for the most part, it remains an incurable disease. For this… read more here.
Keywords: management; multiple myeloma; panobinostat management; management multiple ... See more keywords